Income Statement JD Health International Inc.

Equities

6618

KYG5074A1004

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 08:08:20 13/03/2026 GMT			5-day change	1st Jan Change
49.00 ^HKD	-1.29%		+3.16%	-11.71%

03-05	JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-05	Oil Outlook, Values Drive Asian Stock Markets Higher	MT

f7ef813ee6cba2a2ce5.8n8kQbWZkTkptetCGmaohiVvdx2tUlMWX3enIs0PaWY.u05PBsPPp3hE0o4YVVPPzm0VRkzJAip5JzrQfaVkXQC1CEAS-vfkS376gA

Published financial data: JD HEALTH INTERNATIONAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	19.38B	30.68B	46.74B	53.53B	58.16B
Total Revenues	19.38B	30.68B	46.74B	53.53B	58.16B
Cost of Goods Sold, Total	14.47B	23.48B	36.84B	41.66B	44.85B
Gross Profit	4.92B	7.2B	9.89B	11.87B	13.31B
Selling General & Admin Expenses, Total	3.89B	7.67B	8.87B	9.94B	10.5B
Provision for Bad Debts	117K	38.35M	98.2M	69.86M	316M
R&D Expenses	609M	893M	1.07B	1.23B	1.33B
Other Operating Expenses, Total	4.5B	8.6B	10.04B	11.23B	12.15B
Operating Income	415M	-1.4B	-145M	631M	1.16B
Interest Expense, Total	-3.42M	-6M	-9.1M	-9.48M	-8.19M
Interest And Investment Income	149M	458M	864M	1.95B	1.96B
Net Interest Expenses	146M	452M	855M	1.94B	1.95B
Income (Loss) On Equity Invest.	-77.02M	-94.16M	-96.76M	-70.76M	-85.53M
Other Non Operating Income (Expenses)	47.44M	145M	82.52M	194M	1.77B
EBT, Excl. Unusual Items	531M	-901M	696M	2.69B	4.8B
Other Unusual Items	-17.6B	-	-	-	-
EBT, Incl. Unusual Items	-17.07B	-901M	696M	2.69B	4.8B
Income Tax Expense	163M	171M	313M	550M	640M
Earnings From Continuing Operations	-17.23B	-1.07B	383M	2.14B	4.16B
Net Income to Company	-17.23B	-1.07B	383M	2.14B	4.16B
Minority Interest	534K	-689K	-3.12M	-1.04M	4.83M
Net Income - (IS)	-17.23B	-1.07B	380M	2.14B	4.16B
Net Income to Common Incl Extra Items	-17.23B	-1.07B	380M	2.14B	4.16B
Net Income to Common Excl. Extra Items	-17.23B	-1.07B	380M	2.14B	4.16B
Per Share Items
Net EPS - Basic	-7.8	-0.35	0.12	0.69	1.32
Basic EPS - Continuing Operations	-7.8	-0.35	0.12	0.69	1.32
Basic Weighted Average Shares Outstanding	2.21B	3.09B	3.11B	3.12B	3.14B
Net EPS - Diluted	-7.8	-0.35	0.12	0.68	1.32
Diluted EPS - Continuing Operations	-7.8	-0.35	0.12	0.68	1.32
Diluted Weighted Average Shares Outstanding	2.21B	3.09B	3.14B	3.16B	3.16B
Normalized Basic EPS	0.15	-0.18	0.14	0.54	0.96
Normalized Diluted EPS	0.15	-0.18	0.14	0.53	0.95
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	428M	-1.37B	-60.93M	795M	1.31B
EBITA	415M	-1.4B	-145M	756M	1.28B
EBIT	415M	-1.4B	-145M	631M	1.16B
Effective Tax Rate - (Ratio)	-0.95	-19	44.92	20.44	13.34
Current Domestic Taxes	183M	227M	414M	454M	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	183M	227M	414M	454M	504M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-20.49M	-55.64M	-102M	96.2M	135M
Normalized Net Income	333M	-564M	432M	1.68B	3B
Interest on Long-Term Debt	3.42M	6M	9.1M	9.48M	8.19M
Supplemental Operating Expense Items
Advertising Expense	-	-	922M	1.3B	1.56B
Selling and Marketing Expenses	1.43B	2.13B	2.2B	2.65B	3.05B
General and Administrative Expenses	464M	2.54B	2.15B	2B	1.42B
Research And Development Expense From Footnotes	609M	893M	1.07B	1.23B	1.33B
Stock-Based Comp., R&D Exp. (Total)	26.5M	98.86M	106M	106M	80.18M
Stock-Based Comp., S&M Exp. (Total)	7.31M	37.94M	49.38M	40.29M	25.61M
Stock-Based Comp., G&A Exp. (Total)	312M	2.31B	1.81B	1.57B	930M
Stock-Based Comp., SG&A Exp. (Total)	34.09M	134M	142M	126M	94.15M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	380M	2.58B	2.1B	1.85B	1.13B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	32.27B	17.25B	18.72B	15.04B	22.63B
Short Term Investments	6.52B	23.64B	27.95B	16.8B	18.17B
Trading Asset Securities, Total	1.51B	1.1B	1B	9.38B	10.44B
Total Cash And Short Term Investments	40.3B	41.99B	47.67B	41.22B	51.24B
Accounts Receivable, Total	461M	406M	1.3B	707M	858M
Other Receivables	81.15M	51.16M	687M	265M	289M
Total Receivables	542M	457M	1.99B	972M	1.15B
Inventory	1.73B	3.04B	6B	5.08B	5.84B
Prepaid Expenses	6.67M	14.03M	15.79M	16.35M	20.72M
Restricted Cash	38.6M	25.35M	33M	15.38M	32.66M
Other Current Assets, Total	81.69M	178M	742M	540M	182M
Total Current Assets	42.7B	45.71B	56.45B	47.85B	58.46B
Net Property Plant And Equipment	115M	261M	252M	288M	796M
Long-term Investments	714M	1.03B	1.52B	13.2B	9.58B
Other Intangibles, Total	28.5M	25.39M	2.27B	2.18B	2.09B
Loans Receivable Long-Term	235M	-	-	-	-
Deferred Tax Assets Long-Term	21.69M	95.86M	208M	300M	313M
Other Long-Term Assets, Total	176M	884M	579M	472M	26.88M
Total Assets	43.99B	48B	61.28B	64.29B	71.27B
Liabilities
Accounts Payable, Total	2.9B	5.71B	11.14B	11.34B	12.48B
Accrued Expenses, Total	172M	178M	1.2B	306M	392M
Current Portion of Leases	28.57M	67.55M	70.65M	95.32M	110M
Current Income Taxes Payable	132M	119M	380M	338M	207M
Unearned Revenue Current, Total	179M	395M	1.37B	406M	538M
Other Current Liabilities	1.27B	1.53B	2.18B	2.1B	1.79B
Total Current Liabilities	4.68B	8.01B	16.36B	14.58B	15.52B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	61.41M	134M	129M	119M	149M
Deferred Tax Liability Non Current	-	8.89M	7.82M	214M	364M
Total Liabilities	4.74B	8.15B	16.49B	14.92B	16.03B
Common Stock, Total	11K	11K	11K	11K	11K
Additional Paid In Capital	55.63B	56.24B	57.06B	58.55B	59.98B
Retained Earnings	-18.6B	-19.68B	-19.38B	-17.34B	-13.22B
Treasury Stock	-	-50.64M	-34.3M	-92.57M	-60.73M
Comprehensive Income and Other	2.22B	3.34B	7.13B	8.23B	8.54B
Total Common Equity	39.25B	39.85B	44.78B	49.36B	55.23B
Minority Interest	501K	1.19M	4.31M	14.51M	9.68M
Total Equity	39.25B	39.85B	44.78B	49.37B	55.24B
Total Liabilities And Equity	43.99B	48B	61.28B	64.29B	71.27B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.18B	3.1B	3.11B	3.13B	3.15B
ECS Total Common Shares Outstanding	3.18B	3.1B	3.11B	3.13B	3.15B
Book Value / Share	12.33	12.86	14.42	15.78	17.56
Tangible Book Value	39.22B	39.83B	42.51B	47.17B	53.14B
Tangible Book Value Per Share	12.32	12.86	13.69	15.08	16.89
Total Debt	89.98M	201M	199M	215M	258M
Net Debt	-40.21B	-41.79B	-47.47B	-41.01B	-50.98B
Minority Interest, Total (Incl. Fin. Div)	501K	1.19M	4.31M	14.51M	9.68M
Equity Method Investments, Total	606M	512M	418M	348M	264M
Account Code - Inventory Valuation	6	6	6	-	6
Inventories - Finished Goods, Total	1.82B	3.11B	6.26B	5.47B	5.99B
Full Time Employees	2.1K	3.3K	2.74K	3.12K	3.56K
Accumulated Allowance for Doubtful Accounts (Supple)	6.37M	44.72M	143M	213M	220M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-17.23B	-1.07B	380M	2.14B	4.16B
Depreciation & Amortization - CF	27.22M	63.17M	141M	103M	95.86M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	125M	119M
Depreciation & Amortization, Total	27.22M	63.17M	141M	227M	215M
(Gain) Loss on Sale of Investments - (CF)	-60.5M	-94.21M	106M	-93.51M	-1.35B
Provision for Credit Losses	117K	-	-	-	-
(Income) Loss On Equity Investments - (CF)	77.02M	94.16M	96.76M	70.76M	85.53M
Stock-Based Compensation (CF)	380M	2.58B	2.1B	1.85B	1.13B
Provision and Write-off of Bad Debts	-	38.35M	98.2M	69.86M	316M
Other Operating Activities, Total	17.59B	-204M	130M	126M	-755M
Change In Accounts Receivable	-47.66M	-331M	-685M	537M	-213M
Change In Inventories	-522M	-1.29B	-3.15B	792M	-523M
Change In Accounts Payable	2.45B	2.59B	5.04B	-866M	760M
Change in Unearned Revenues	91.78M	216M	980M	-969M	132M
Change in Other Net Operating Assets	946M	843M	665M	721M	369M
Cash from Operations	3.7B	3.43B	5.91B	4.6B	4.33B
Capital Expenditure	-15.7M	-502M	-40.16M	-61.18M	-38.6M
Cash Acquisitions	-3.5M	-	-	-	-
Sale (Purchase) of Intangible assets	-21.91M	-7.88M	-2.23B	-	-
Investment in Marketable and Equity Securities, Total	-7.56B	-17.25B	-1.96B	-7.97B	3.21B
Other Investing Activities, Total	-243M	5.18M	-5.41M	9.48M	-25.04M
Cash from Investing	-7.84B	-17.75B	-4.24B	-8.02B	3.15B
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-217M	-	-	-	-
Long-Term Debt Repaid, Total	-26.21M	-32.33M	-47.56M	-33.83M	-37.41M
Total Debt Repaid	-243M	-32.33M	-47.56M	-33.83M	-37.41M
Issuance of Common Stock	25.79B	-	-	-	-
Repurchase of Common Stock	-	-56.3M	-869M	-69.1M	-
Issuance of Preferred Stock	6.48B	-	-	-	-
Other Financing Activities, Total	-2.44M	-75.02M	-8.85M	-14.26M	-8.19M
Cash from Financing	32.03B	-164M	-925M	-117M	-45.61M
Foreign Exchange Rate Adjustments	-580M	-533M	721M	-145M	159M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	27.31B	-15.02B	1.47B	-3.68B	7.59B
Supplemental Items
Cash Interest Paid	2.44M	4.91M	8.85M	9.48M	8.19M
Cash Income Tax Paid (Refund)	175M	250M	153M	497M	635M
Levered Free Cash Flow	3.6B	3.22B	3.16B	2.75B	2.35B
Unlevered Free Cash Flow	3.6B	3.23B	3.17B	2.76B	2.36B
Change In Net Working Capital	-2.98B	-1.97B	-3.29B	-351M	-326M
Net Debt Issued / Repaid	-243M	-32.33M	-47.56M	-33.83M	-37.41M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	0.99	-1.91	-0.17	0.63	1.07
Return on Total Capital	1.12	-2.21	-0.21	0.83	1.38
Return On Equity %	-88.86	-2.71	0.91	4.55	7.95
Return on Common Equity	-88.86	-2.71	0.9	4.55	7.96
Margin Analysis
Gross Profit Margin %	25.37	23.46	21.16	22.17	22.88
SG&A Margin	20.08	25	18.98	18.57	18.05
EBITDA Margin %	2.21	-4.47	-0.13	1.48	2.26
EBITA Margin %	2.14	-4.58	-0.31	1.41	2.2
EBIT Margin %	2.14	-4.58	-0.31	1.18	2
Income From Continuing Operations Margin %	-88.92	-3.5	0.82	4	7.15
Net Income Margin %	-88.92	-3.5	0.81	4	7.16
Net Avail. For Common Margin %	-88.92	-3.5	0.81	4	7.16
Normalized Net Income Margin	1.72	-1.84	0.92	3.14	5.16
Levered Free Cash Flow Margin	18.59	10.5	6.77	5.14	4.05
Unlevered Free Cash Flow Margin	18.6	10.51	6.78	5.15	4.05
Asset Turnover
Asset Turnover	0.74	0.67	0.86	0.85	0.86
Fixed Assets Turnover	295.46	163.3	182.32	198.29	107.31
Receivables Turnover (Average Receivables)	27.45	70.82	54.76	53.32	74.34
Inventory Turnover (Average Inventory)	9.61	9.84	8.15	7.52	8.21
Short Term Liquidity
Current Ratio	9.12	5.71	3.45	3.28	3.77
Quick Ratio	8.72	5.3	3.04	2.89	3.37
Operating Cash Flow to Current Liabilities	0.79	0.43	0.36	0.32	0.28
Days Sales Outstanding (Average Receivables)	13.33	5.15	6.66	6.85	4.92
Days Outstanding Inventory (Average Inventory)	38.09	37.1	44.76	48.54	44.58
Average Days Payable Outstanding	41.02	63.38	77.28	100.68	95.59
Cash Conversion Cycle (Average Days)	10.4	-21.13	-25.85	-45.3	-46.08
Long Term Solvency
Total Debt/Equity	0.23	0.5	0.45	0.43	0.47
Total Debt / Total Capital	0.23	0.5	0.44	0.43	0.47
LT Debt/Equity	0.16	0.34	0.29	0.24	0.27
Long-Term Debt / Total Capital	0.16	0.33	0.29	0.24	0.27
Total Liabilities / Total Assets	10.78	16.97	26.91	23.2	22.5
EBIT / Interest Expense	121.56	-234.05	-15.95	66.51	141.92
EBITDA / Interest Expense	129.53	-223.52	-0.49	90.49	168.12
(EBITDA - Capex) / Interest Expense	124.94	-307.23	-4.9	84.04	163.41
Total Debt / EBITDA	0.2	-0.15	-44.87	0.25	0.19
Net Debt / EBITDA	-90.88	31.17	10.68K	-47.78	-37
Total Debt / (EBITDA - Capex)	0.21	-0.11	-4.47	0.27	0.19
Net Debt / (EBITDA - Capex)	-94.23	22.67	1.06K	-51.44	-38.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	78.77	58.3	52.32	14.54	8.65
Gross Profit, 1 Yr. Growth %	74.85	46.37	37.43	19.95	12.16
EBITDA, 1 Yr. Growth %	-2	-476.3	-95.56	-1.4K	65.41
EBITA, 1 Yr. Growth %	-3.78	-499.33	-89.66	-892.88	69.63
EBIT, 1 Yr. Growth %	-3.78	-499.33	-89.66	-534.71	84.34
Earnings From Cont. Operations, 1 Yr. Growth %	1.67K	-93.78	-135.72	459.16	93.99
Net Income, 1 Yr. Growth %	1.67K	-93.77	-135.41	463.49	94.31
Normalized Net Income, 1 Yr. Growth %	24.23	-94.71	-176.54	289.64	78.49
Diluted EPS Before Extra, 1 Yr. Growth %	1.63K	-95.56	-134.29	466.67	94.12
Accounts Receivable, 1 Yr. Growth %	-51.55	-11.97	220.72	-45.68	21.39
Inventory, 1 Yr. Growth %	35.52	75.55	97.16	-15.2	14.91
Net Property, Plant and Equip., 1 Yr. Growth %	610.14	126.75	-3.4	14.32	176.39
Total Assets, 1 Yr. Growth %	407.04	9.11	27.66	4.91	10.87
Tangible Book Value, 1 Yr. Growth %	-8.63K	1.54	6.74	10.96	12.64
Common Equity, 1 Yr. Growth %	-8.65K	1.54	12.36	10.22	11.9
Cash From Operations, 1 Yr. Growth %	803.48	-7.26	72.13	-22.02	-5.92
Capital Expenditures, 1 Yr. Growth %	202.72	3.1K	-92	52.35	-36.91
Levered Free Cash Flow, 1 Yr. Growth %	1.11K	-9.58	-1.8	-12.98	-14.54
Unlevered Free Cash Flow, 1 Yr. Growth %	1.02K	-9.52	-1.73	-12.95	-14.53
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	54.04	68.22	55.28	32.09	11.55
Gross Profit, 2 Yr. CAGR %	57.63	59.98	41.83	28.4	15.99
EBITDA, 2 Yr. CAGR %	18.02	77.19	-59.11	-23.87	364.54
EBITA, 2 Yr. CAGR %	17.12	80.37	-35.75	-26.64	266.74
EBIT, 2 Yr. CAGR %	17.12	80.37	-35.75	-32.97	183.08
Earnings From Cont. Operations, 2 Yr. CAGR %	795.49	5.07	-85.09	41.33	229.35
Net Income, 2 Yr. CAGR %	795.47	5.1	-85.15	41.25	230.9
Normalized Net Income, 2 Yr. CAGR %	31.83	45.15	-79.88	72.69	163.72
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-12.41	-87.6	39.39	231.66
Accounts Receivable, 2 Yr. CAGR %	376.02	-34.69	68.02	31.99	-18.8
Inventory, 2 Yr. CAGR %	24.63	54.24	86.04	29.3	-1.29
Net Property, Plant and Equip., 2 Yr. CAGR %	413.06	301.28	48	5.09	77.76
Total Assets, 2 Yr. CAGR %	510.05	135.21	18.02	15.73	7.85
Tangible Book Value, 2 Yr. CAGR %	624.88	830.87	4.11	8.83	11.8
Common Equity, 2 Yr. CAGR %	623.8	831.78	6.81	11.28	11.06
Cash From Operations, 2 Yr. CAGR %	344.51	189.46	26.34	15.85	-14.35
Capital Expenditures, 2 Yr. CAGR %	179.26	884.07	59.94	-65.1	-1.96
Levered Free Cash Flow, 2 Yr. CAGR %	383.08	228.35	-5.77	-7.56	-13.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	383.08	216.98	-5.71	-7.51	-13.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	51.69	55.44	62.75	40.3	23.76
Gross Profit, 3 Yr. CAGR %	52.72	53.78	52.08	34.13	22.74
EBITDA, 3 Yr. CAGR %	18.33	64.63	-48.14	29.68	-1.4
EBITA, 3 Yr. CAGR %	17.45	66.77	-30.46	29.05	-2.99
EBIT, 3 Yr. CAGR %	17.45	66.77	-30.46	21.51	-6.09
Earnings From Cont. Operations, 3 Yr. CAGR %	358.74	70.9	-26.67	-50.09	57.07
Net Income, 3 Yr. CAGR %	358.73	70.94	-26.87	-50.1	57.09
Normalized Net Income, 3 Yr. CAGR %	27.63	43.38	17.26	-45.98	74.6
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-35.74	-55.67	55.66
Accounts Receivable, 3 Yr. CAGR %	428.33	171.2	11.01	15.32	28.36
Inventory, 3 Yr. CAGR %	25.14	39.71	67.4	43.18	24.31
Net Property, Plant and Equip., 3 Yr. CAGR %	212.68	290.81	149.63	35.8	45.06
Total Assets, 3 Yr. CAGR %	264.11	243.71	91.86	13.48	14.08
Tangible Book Value, 3 Yr. CAGR %	290.85	276.47	352.24	6.35	10.09
Common Equity, 3 Yr. CAGR %	289.82	276.08	360.34	7.94	11.49
Cash From Operations, 3 Yr. CAGR %	367.89	163.64	143.41	7.57	8.09
Capital Expenditures, 3 Yr. CAGR %	165.17	529.53	97.84	57.37	-57.48
Levered Free Cash Flow, 3 Yr. CAGR %	-	175.32	119.58	-8.24	-9.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	175.37	114.53	-8.19	-9.91
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	53.12	45.64	39.93
Gross Profit, 5 Yr. CAGR %	-	-	48.27	43.08	36.46
EBITDA, 5 Yr. CAGR %	-	-	-25.1	20.93	24.65
EBITA, 5 Yr. CAGR %	-	-	-10.75	20.07	24.32
EBIT, 5 Yr. CAGR %	-	-	-10.75	15.82	21.93
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	16.51	58.4	33.73
Net Income, 5 Yr. CAGR %	-	-	16.32	58.38	33.76
Normalized Net Income, 5 Yr. CAGR %	-	-	21.96	54.45	62.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	23.9
Accounts Receivable, 5 Yr. CAGR %	-	-	234.11	103.32	-2.04
Inventory, 5 Yr. CAGR %	-	-	46.65	35.45	35.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	131.83	131.1	117.92
Total Assets, 5 Yr. CAGR %	-	-	132.02	122.38	52.38
Tangible Book Value, 5 Yr. CAGR %	-	-	130.25	129.16	158.58
Common Equity, 5 Yr. CAGR %	-	-	132.25	131.07	160.66
Cash From Operations, 5 Yr. CAGR %	-	-	177.14	89.74	60.29
Capital Expenditures, 5 Yr. CAGR %	-	-	116.62	97.95	49.4
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	77.93	51.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	77.99	49.01